Steve Basta has served as Chief Executive Officer of Menlo Therapeutics, Inc. since September 2015. Prior to joining Menlo Therapeutics, Mr. Basta served from 2011 to 2015 as CEO of AlterG, Inc. a privately held rehabilitation company which commercializes the AlterG Anti-Gravity Treadmill.
From 2002 through 2011, Mr. Basta served as CEO of BioForm Medical, Inc. and its successor, Merz Aesthetics, Inc. Mr. Basta led BioForm’s growth from initial product launch to $80 million in annual revenues at the time of it’s acquisition by Merz, and subsequently led Merz Aesthetics through multiple product launches managing a global business unit which was the #3 worldwide injectable aesthetics business.
Prior to Bioform Medical, Mr. Basta served as President and CEO of Gliatech, Inc., a medical device company, VP Business Development and Chief Financial Officer of Creative BioMolecules, Inc., a protein therapy and drug device combination products company, and Executive Director of Product Development for The Immune Response Corporation, a biotechnology company.
Mr. Basta also served for two years as an associate with the investment banking firm, Dillon, Read & Co. Inc. Mr. Basta received his MBA from the Kellogg Graduate School of Business at Northwestern University, and his bachelor’s degree in biomedical engineering from The Johns Hopkins University.